NEUROFIBROMATOZIS AND ATTENTION DEFICIT

Yıl 2010, Cilt: 12 Sayı: 1, 94 - 97, 01.03.2010

Mehmet Emin Yanık Mehmet Eryılmaz Abdulkadir Koçer Cihangir Aliağaoğlu Emel Koçer

Öz

Neurofibromatosis type VI, a disease characterized by the presence of café-au-lait spots withoutthe presence of neurofibromas typically present in neurofibromatosis, as well as cognitivefunction and speech problems, often shows neurological involvement. We describe a case of a14-year-old child who has speech problems and isolated cafè-au-lait macules. We performedan IQ test on him and he scored 70 points. His problems started when he was approximately 5years old (school age). He was diagnosed with attention deficit disorder syndrome withouthyperactivity after neuropsychiatric investigation. We reported this case to improve recognitionof NF VI in children who have cognitive function problems

Anahtar Kelimeler

Cafe au leait spots, Attention deficit, Mental retardation, Neurofibromatosis

Nörofibromatozis ve Dikkat Eksikliği

Öz

Nörofibromatoz tip VI (NF tip VI), nörofibromlar olmadan cafe au leait lekeleri varlığı ile NF1’den ayırt edilir. Bilişsel fonksiyon problemleri ve konuşma problemleri sinir sistemitutulumunu gösterir. Bu makalede konuşma bozukluğu ve derslerinde başarısızlık şikayetleriylekliniğimize başvuran; dermatolojik muayenede izole cafe au leait lekeleri saptanan ve IQtestinden 70 puan alan 14 yaşında çocuk hasta takdim edildi. Bu şikayetlerinin 5 yaşındanitibaren (okul çağına başladıktan sonra) dikkati çektiği ifade ediliyordu. Nöropsikiyatrikincelemeler sonrasında dikkat eksikliği bozukluğu sendromu (hiperaktivitenin eşlik etmediği)tanısı alan olgumuz, bilişsel fonksiyon bozukluğu olan çocuk yaştaki olgularda unutulmamasıgereken nadir bir tanı olarak NF tip VI’yı hatırlatma düşüncesiyle sunuldu

Anahtar Kelimeler

Cafe au leait lekeleri, Dikkat eksiklği, Zeka geriliği, Nörofibromatöz

Kaynakça

• Ricardi VM. Von Recklinghausen neurofibromatosis. N Eng J Med 305:1617-27, 1981.
• Yohay K. Nuerofibromatosis types 1 and 2. Neurologist 12:86-93, 2006.
• National Institutes of Health Consensus Development Conference Statement on Neurofibromatosis. Arch Neurol 45;575-8,1988.
• Ruggieri M. The different forms of neurofibromatosis. Childs Nerv Syst. 15:295-308, 1999.
• Pascual-Castroviejo I, Pascual-Pascual SI, Velázquez-Fragua R, Viaño J, López-Gutiérrez JC.Segmental neurofibromatosis in children. Presentation of 43 patients. Rev Neurol. 47:399- 403, 2008.
• Wolkenstein P. Isolated CAL lesions do not require medical care. CAL spots are benign and may resolve with age. Orphanet: Neurofibromatosis type 6,2009. (www.orpha.net/consor/cgi- bin/OC_Exp.php?lng=EN).
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 2nd, 3rd, 3-revised, 4th eds. Washington, DC: American Psychiatric Association; 1968, 1980, 1987,1994.
• Pinson S, Créange A, Barbarot S, Stalder JF, Chaix Y, Rodriguez D, Sanson M, Bernheim A, D'incan M, Doz F, Stoll C, Combemale P, Kalifa C, Zeller J, Teillac-Hamel D, Lyonnet S, Zerah M, Lacour JP, Guillot B, Wolkenstein P. Recommendations for the treatment of neurofibromatosis type 1. J Fr Ophtalmol. 25(4):423-33, 2002.
• North KN, Riccardi V, Samango-Sprouse C, Ferner R, Moore B, Legius E et al. Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force. Neurology, 48:1121-7, 1997.
• Ferner RE, Hughes RA, Weinman J. Intellectual impairment in neurofibromatosis I. J Neurol Sci 138:125-33, 1996.
• Legius E, Descheemaeker MJ, Spaepen A, Casaer P, Fryns JP. Genet Couns. Neurofibromatosis type 1 in childhood: a study of the neuropsychological profile in 45 children. 5(1):51-60, 1994
• Moore BD, Slopis JM, Schomer D, Jackson EF, Levy BM. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology. 46(6):1660-8, 1996.
• J. Gordon Millichap JG. Etiologic Classification of Attention-Deficit/Hyperactivity Disorder. Pediatrics 121:358-65, 2008.
• Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, March JS, Arnold LE, Cantwell DP, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Pelham WE, Severe JB, Swanson JM, Wells KC, Wigal T, Vitiello. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. B.J Am Acad Child Adolesc Psychiatry.40(2):147-58, 2001.
• Woods SP, Lovejoy DW, Ball JD. Neuropsychological characteristics of adults with ADHD: a comprehensive review of initial studies. Clin Neuropsychol. 16(1):12-34, 2002.